Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPension (IS)Profit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Harvard Bioscience (HBIO) Tax Provisions (2016 - 2025)

Harvard Bioscience (HBIO) has disclosed Tax Provisions for 16 consecutive years, with $167000.0 as the latest value for Q4 2025.

  • Quarterly Tax Provisions fell 36.26% to $167000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$157000.0 through Dec 2025, down 143.37% year-over-year, with the annual reading at -$133000.0 for FY2025, 130.93% down from the prior year.
  • Tax Provisions for Q4 2025 was $167000.0 at Harvard Bioscience, up from $100000.0 in the prior quarter.
  • The five-year high for Tax Provisions was $986000.0 in Q2 2022, with the low at -$1.3 million in Q3 2022.
  • Average Tax Provisions over 5 years is $87400.0, with a median of $183500.0 recorded in 2024.
  • The sharpest move saw Tax Provisions tumbled 697.67% in 2022, then surged 685.0% in 2023.
  • Over 5 years, Tax Provisions stood at $541000.0 in 2021, then soared by 43.07% to $774000.0 in 2022, then tumbled by 37.08% to $487000.0 in 2023, then plummeted by 46.2% to $262000.0 in 2024, then tumbled by 36.26% to $167000.0 in 2025.
  • According to Business Quant data, Tax Provisions over the past three periods came in at $167000.0, $100000.0, and $30000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.